European Commission

Shingrix is a non-live, recombinant subunit vaccine to be given intramuscularly in two doses for the prevention of shingles…

The approval facilitates availability of Vaxneuvance for this population in all 27 European Union (EU) member states plus Iceland,…

Order for approximately $10 million funded by the European Commission and orders for approximately $6 million received from two…

Vabysmo is the only injectable eye medicine approved in Europe with phase-III studies supporting treatment at intervals of up to…

The European Union's executive said in a statement that 14 countries are participating in the agreement, under which they can…

Cibinqo is a once-daily oral treatment with proven efficacy demonstrated in a large-scale clinical trial programme

Gavreto is the first and only precision medicine approved in the EU for the first-line treatment of people with RET…

The decision follows one day after the positive opinion by the EMA Committee for CHMP, reflecting the EMA and the European…

Under the agreement, AstraZeneca commits to deliver 60 million doses of the vaccine by the end of the third quarter 2021, 75…

This once-daily treatment is an alternative to the currently-approved Xeljanz 5 mg twice-daily treatment of PsA